GNI Group Ltd.
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
2160 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目２番２号
- Website:
- https://www.gnipharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GNI Group Ltd. is a multinational, vertically integrated biopharmaceutical company engaged in the research, clinical development, manufacturing, and commercialization of pharmaceutical drugs and medical devices. The company focuses on developing novel treatments for intractable conditions with unmet medical needs, particularly in the areas of cancer and inflammatory diseases. With core operations spanning Japan, China, and the US, GNI Group leverages genetic analysis technology in its drug discovery pipeline. Its key commercial products include Etuary (pirfenidone) for the treatment of idiopathic pulmonary fibrosis.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GNI Group Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-14 10:05 |
Regulatory News Service
確認書
|
Japanese | 10.0 KB | |
| 2025-08-14 09:30 |
Interim Report
半期報告書－第25期(2025/01/01－2025/12/31)
|
Japanese | 296.9 KB | |
| 2025-07-25 04:00 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 28.9 KB | |
| 2025-07-24 10:09 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 40.7 KB | |
| 2025-04-23 09:00 |
Regulatory News Service
臨時報告書
|
Japanese | 32.7 KB | |
| 2025-03-31 09:00 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2025-03-31 09:00 |
Regulatory News Service
内部統制報告書－第24期(2024/01/01－2024/12/31)
|
Japanese | 22.2 KB | |
| 2025-03-31 09:00 |
Annual Report
有価証券報告書－第24期(2024/01/01－2024/12/31)
|
Japanese | 1.2 MB | |
| 2025-03-28 03:30 |
Regulatory News Service
臨時報告書
|
Japanese | 21.6 KB | |
| 2024-08-14 10:08 |
Regulatory News Service
臨時報告書
|
Japanese | 19.0 KB | |
| 2024-08-14 09:26 |
Interim Report
半期報告書－第24期(2024/01/01－2024/12/31)
|
Japanese | 301.9 KB | |
| 2024-08-14 09:26 |
Regulatory News Service
確認書
|
Japanese | 10.0 KB | |
| 2024-07-02 08:00 |
Regulatory News Service
訂正報告書（大量保有報告書・変更報告書）
|
Japanese | 51.9 KB | |
| 2024-06-28 09:00 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 52.6 KB | |
| 2024-05-30 09:30 |
Regulatory News Service
臨時報告書
|
Japanese | 32.3 KB |
Automate Your Workflow. Get a real-time feed of all GNI Group Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GNI Group Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
